Modulation of G0S2 expression affects GBM responses to IR treatments in vitro and in vivo through mTOR/S6K/RNF168/53BP1-regulated DNA repair, suggesting G0S2 as a potential mediator of glioma responses to IR. The gene discussed is TP53BP1; the disease is glioma.